All ProductsDisplaying Products by Catalog Number (4100 - 4199)
01000200030004000500060007000800090010001100120013001400150016001700180019002000210022002300240025002600270028002900300031003200330034003500360037003800390040004100420043004400450046004700480049005000510052005300540055005600570058005900600061006200630064006500660067006800690070007100720073007400750076007700780079008000810082008300840085008600870088008900
| Cat. No. | Product Name / Activity |
|---|---|
| 4100 | HC 067047 |
| Potent and selective TRPV4 antagonist | |
| 4102 | Mycophenolate mofetil |
| Inosine monophosphate dehydrogenase (IMPDH) inhibitor | |
| 4105 | CIQ |
| Potentiator of NMDA receptors containing GluN2C/GluN2D | |
| 4106 | Nicotinamide |
| PARP-1 inhibitor | |
| 4107 | Probenecid |
| MRP and OAT3 inhibitor | |
| 4108 | Quinidine |
| Blocks sodium and potassium channels | |
| 4109 | Chloroquine diphosphate |
| Antimalarial; inhibits apoptosis and autophagy | |
| 4110 | Oligomycin A |
| Inhibitor of mitochondrial ATPase | |
| 4116 | GSK 9027 |
| Glucocorticoid receptor agonist | |
| 4117 | Bepridil hydrochloride |
| Non-selective Ca2+ channel blocker; also NCX inhibitor | |
| 4118 | SB 772077B dihydrochloride |
| Potent Rho-kinase inhibitor; vasodilator | |
| 4124 | Pioglitazone hydrochloride |
| Selective PPARγ agonist; antidiabetic agent | |
| 4126 | DMH-1 |
| Selective ALK2 inhibitor | |
| 4130 | KN 92 |
| Inactive analog of KN 93. K+ channel (Kv) blocker | |
| 4132 | XMD 8-92 |
| ERK5/BMK1 inhibitor; also BRD4 inhibitor | |
| 4133 | U 73343 |
| Analog of U 73122 (Cat. No. 1268) | |
| 4134 | NPS 2390 |
| Group I mGlu antagonist | |
| 4137 | Hygromycin B |
| Aminoglycoside antibiotic; active against prokaryotic and eukaryotic cells | |
| 4139 | Aprotinin |
| Competitive serine protease inhibitor | |
| 4140 | EB 47 |
| Potent PARP-1 inhibitor | |
| 4141 | LY 2087101 |
| Allosteric potentiator of α7, α4β2 and α4β4 nAChRs | |
| 4143 | GSK 2334470 |
| Highly potent, selective PDPK1 (PDK1) inhibitor | |
| 4144 | GSK 690693 |
| Akt kinase inhibitor. Antitumor | |
| 4153 | Phorbol 12,13-dibutyrate |
| Protein kinase C activator | |
| 4154 | TCN 201 |
| GluN1/GluN2A-selective NMDA antagonist | |
| 4165 | Gisadenafil besylate |
| Potent PDE5 inhibitor; orally bioavailable | |
| 4166 | NS 5806 |
| KV4.3 channel activator | |
| 4167 | KW 3902 |
| Selective A1 antagonist | |
| 4169 | KS 176 |
| Selective BCRP inhibitor | |
| 4171 | VU 0364739 hydrochloride |
| Potent and selective PLD2 inhibitor | |
| 4172 | ML 145 |
| GPR35 antagonist | |
| 4173 | MDL 100907 |
| Potent and selective 5-HT2A antagonist | |
| 4174 | Pramipexole dihydrochloride |
| Selective D3 agonist | |
| 4175 | PF 3845 |
| Selective FAAH inhibitor | |
| 4179 | AMD 3465 hexahydrobromide |
| Potent and selective CXCR4 antagonist | |
| 4181 | Ro 3306 |
| Cdk1 inhibitor | |
| 4186 | UK 5099 |
| MCT inhibitor; also inhibits mitochondrial pyruvate carrier | |
| 4188 | UK 383367 |
| Potent and selective BMP-1 (PCP) inhibitor | |
| 4189 | SC 26196 |
| Selective fatty acid desaturase 2 inhibitor | |
| 4192 | PD 0325901 |
| Potent inhibitor of MEK1/2 | |
| 4193 | CP 100356 hydrochloride |
| P-gp inhibitor | |
| 4195 | VPC 23019 |
| S1P1 and S1P3 antagonist | |
| 4196 | HA 130 |
| Potent and selective autotaxin inhibitor |